Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ascentage Pharma Group In...

    NASDAQ: AAPG · Real-Time Price · USD
    32.00
    0.49 (1.56%)
    At close: Jun 16, 2025, 3:59 PM
    32.35
    1.11%
    After-hours: Jun 16, 2025, 07:25 PM EDT

    Ascentage Pharma International Statistics

    Share Statistics

    Ascentage Pharma International has 86.75M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 86.75M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 83

    FTD / Avg. Volume

    n/a
    		 0.28%

    Short Selling Information

    The latest short interest is 9.62K, so 0.01% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 9.62K

    Short % of Shares Out

    n/a
    		 0.01%

    Short % of Float

    n/a
    		 0.01%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -23.63 and the forward PE ratio is 38.04. Ascentage Pharma International's PEG ratio is 0.25.

    PE Ratio

    n/a
    		 -23.63

    Forward PE

    n/a
    		 38.04

    PS Ratio

    n/a
    		 9.77

    Forward PS

    n/a
    		 11.5

    PB Ratio

    n/a
    		 36.26

    P/FCF Ratio

    n/a
    		 -70.62

    PEG Ratio

    n/a
    		 0.25
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Ascentage Pharma International.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.26, with a Debt / Equity ratio of 6.32.

    Current Ratio

    n/a
    		 1.26

    Quick Ratio

    n/a
    		 1.26

    Debt / Equity

    n/a
    		 6.32

    Debt / EBITDA

    n/a
    		 -7.02

    Debt / FCF

    n/a
    		 -12.3

    Interest Coverage

    n/a
    		 -5.74

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,729,541.45

    Profits Per Employee

    n/a
    		 $-715,049.38

    Employee Count

    n/a
    		 567

    Asset Turnover

    n/a
    		 0.37

    Inventory Turnover

    n/a
    		 4.41

    Taxes

    Income Tax

    n/a
    		 10.43M

    Effective Tax Rate

    n/a
    		 -2.64%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.78, so Ascentage Pharma International's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.78

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 24.46

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 71.98

    Average Volume (20 Days)

    n/a
    		 29,369

    Income Statement

    In the last 12 months, Ascentage Pharma International had revenue of 980.65M and earned -405.43M in profits. Earnings per share was -0.75.

    Revenue

    n/a
    		 980.65M

    Gross Profit

    n/a
    		 951.57M

    Operating Income

    n/a
    		 -369.73M

    Net Income

    n/a
    		 -405.43M

    EBITDA

    n/a
    		 -237.63M

    EBIT

    n/a
    		 -330.8M

    Earnings Per Share (EPS)

    n/a
    		 -0.75
    Full Income Statement

    Balance Sheet

    The company has 1.24B in cash and 1.67B in debt, giving a net cash position of -431.92M.

    Cash & Cash Equivalents

    n/a
    		 1.24B

    Total Debt

    n/a
    		 1.67B

    Net Cash

    n/a
    		 -431.92M

    Retained Earnings

    n/a
    		 -5.77B

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -111.36M and capital expenditures -24.29M, giving a free cash flow of -135.65M.

    Operating Cash Flow

    n/a
    		 -111.36M

    Capital Expenditures

    n/a
    		 -24.29M

    Free Cash Flow

    n/a
    		 -135.65M

    FCF Per Share

    n/a
    		 -1.8
    Full Cash Flow Statement

    Margins

    Gross margin is 97.03%, with operating and profit margins of -37.7% and -41.34%.

    Gross Margin

    n/a
    		 97.03%

    Operating Margin

    n/a
    		 -37.7%

    Pretax Margin

    n/a
    		 -40.31%

    Profit Margin

    n/a
    		 -41.34%

    EBITDA Margin

    n/a
    		 -24.23%

    EBIT Margin

    n/a
    		 -37.7%

    FCF Margin

    n/a
    		 -13.83%

    Dividends & Yields

    AAPG does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for AAPG.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist